Bioprocessing Equipment Market Size, Trends, and Forecast to 2035
According to this latest publication from Meticulous Research®, Most people have never heard of a bioreactor, but there's a reasonable chance one helped make a medicine they've taken. Behind every monoclonal antibody treatment, every mRNA vaccine, and every cell therapy sits a complex chain of manufacturing equipment that coaxes living cells into producing the biological products modern medicine increasingly depends on. The global bioprocessing equipment market was valued at $62.3 billion in 2024 and is expected to grow to around $162 billion by 2035, at a CAGR of 9.2%. That's not flashy growth by tech standards, but it's deep, structural growth tied directly to how the pharmaceutical industry is evolving. Biologics - medicines derived from living cells rather than chemical synthesis - are now among the most important and fastest-growing categories in drug development. Producing them at commercial scale is technically demanding, and the equipment required to do it is ...